Cencora

(New York Stock Exchange)
Back to all articles
Neutral 0

Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release

AI-generated analysis

πŸ“… Cencora Inc. (NYSE: COR) announced it will release its Second Quarter Fiscal 2026 earnings on Wednesday, May 6, 2026, before market open.

πŸ“ž A conference call with CEO Robert P. Mauch and CFO James F. Cleary is scheduled for 8:30 a.m. ET on May 6, 2026.

πŸ’» The live webcast will be available on the company's investor relations website at investor.cencora.com approximately 10 minutes early access recommended.

πŸ“ž Telephone dial-in options are provided for participants in the US/Canada (+1-833-461-5787) and internationally (+1-585-542-9983).

πŸ” The meeting ID is 280720750 with access code 528015 for call participants.

⏱️ A replay of the webcast will be posted on the website approximately one hour after the call concludes and remain available for one year.

🌐 Investors are directed to check investor.cencora.com for any updates regarding live webcast timing or replay information.

🏒 Cencora is a global pharmaceutical solutions organization with over 51,000 employees worldwide dedicated to improving health outcomes for people and animals.

πŸ’° The company ranks #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $300 billion in annual revenue.

🀝 Cencora partners with pharmaceutical innovators across the value chain to facilitate market access for therapies and ensure secure delivery of healthcare products.

Bullish Signals
  • Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500, demonstrating its significant market position.
  • The company generates more than $300 billion in annual revenue, underscoring its scale and financial strength.
  • Cencora operates a large, stable workforce of 51,000+ worldwide team members, indicating operational robustness.
Risk Factors
  • The article primarily announces an earnings release date without providing any substantive financial data, guidance, or forward-looking statements that could inform investors about potential risks or market performance.
  • With the earnings report scheduled for May 6, 2026, there is inherent uncertainty regarding upcoming results that could negatively impact the stock price before the announcement.
Full Analysis
Cencora, Inc. (NYSE: COR) announced on April 1, 2026, that it will release its Second Quarter Fiscal 2026 earnings prior to the opening of trading on Wednesday, May 6, 2026. A conference call to discuss these results is scheduled for 8:30 a.m. ET on the same date and will be webcast on the Company's investor website at investor.cencora.com. Executives participating in the call include Robert P. Mauch, President & Chief Executive Officer, and James F. Cleary, Executive Vice President & Chief Financial Officer. Remote dial-in access details were provided for participants within and outside the United States and Canada. U.S. callers should dial +1 (833) 461-5787, while international callers should use +1 (585) 542-9983. The meeting ID is listed as 280720750 with an access code of 528015. A webcast replay will be available on the investor website approximately one hour after the call concludes and will remain accessible for one year. Cencora describes itself as a leading global pharmaceutical solutions organization focused on improving health outcomes for people and animals, serving care providers with secure delivery of pharmaceuticals and healthcare products. The Company is headquartered in Conshohocken, Pennsylvania, and its headquarters contact information was provided in the press release. The Company reported being ranked #10 on the Fortune 500 and #18 on the Global Fortune 500, with more than $300 billion in annual revenue. Over 51,000 team members worldwide contribute to Cencora's purpose of creating healthier futures. For further updates regarding live webcast timing and replay information, the Company directed users to check investor.cencora.com.